Sumitomo Mitsui Trust Holdings, Inc. Biomarin Pharmaceutical Inc Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 492,104 shares of BMRN stock, worth $26.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
492,104
Previous 467,245
5.32%
Holding current value
$26.1 Million
Previous $33 Million
18.1%
% of portfolio
0.02%
Previous 0.02%
Shares
33 transactions
Others Institutions Holding BMRN
# of Institutions
679Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.01 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$835 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$800 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$651 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $9.84B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...